DA, A., BM, B., JR, T., RW, B., YD, H., HK, H., . . . RM, L. (2014). Dose-related differences in the pharmacodynamic and toxicologic response to a novel hyperglycosylated analog of recombinant human erythropoietin in Sprague-Dawley rats with similarly high hematocrit. Toxicologic pathology, 42(3), 524. https://doi.org/10.1177/0192623313486319
Chicago Style (17th ed.) CitationDA, Andrews, et al. "Dose-related Differences in the Pharmacodynamic and Toxicologic Response to a Novel Hyperglycosylated Analog of Recombinant Human Erythropoietin in Sprague-Dawley Rats with Similarly High Hematocrit." Toxicologic Pathology 42, no. 3 (2014): 524. https://doi.org/10.1177/0192623313486319.
MLA (9th ed.) CitationDA, Andrews, et al. "Dose-related Differences in the Pharmacodynamic and Toxicologic Response to a Novel Hyperglycosylated Analog of Recombinant Human Erythropoietin in Sprague-Dawley Rats with Similarly High Hematocrit." Toxicologic Pathology, vol. 42, no. 3, 2014, p. 524, https://doi.org/10.1177/0192623313486319.
